Your session is about to expire
← Back to Search
N/A
Dextromethorphan for Fibromyalgia
Phase 2
Waitlist Available
Led By Jarred W Younger, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 weeks
Awards & highlights
Summary
This trial is testing if DXM, a common cough medicine ingredient, can reduce pain in people with Fibromyalgia by calming brain inflammation. If successful, it could offer a new way to manage this chronic condition.
Eligible Conditions
- Fibromyalgia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 20 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Daily Self-reported Pain Severity
Secondary study objectives
Daily Self-reported Physical Activity
Patient Global Impression of Change
Side effects data
From 2013 Phase 4 trial • 45 Patients • NCT0176605014%
Headache
100%
80%
60%
40%
20%
0%
Study treatment Arm
Inje Cocktail Alone and Inje Cocktail Plus Belatacept
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: DextromethorphanExperimental Treatment1 Intervention
Participant will take one dextromethorphan 10mg capsule in the morning and at night.
Group II: PlaceboPlacebo Group1 Intervention
Participants will take one placebo capsule in the morning and at night.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dextromethorphan
FDA approved
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,621 Previous Clinical Trials
2,290,951 Total Patients Enrolled
6 Trials studying Fibromyalgia
40,315 Patients Enrolled for Fibromyalgia
Jarred W Younger, PhDPrincipal InvestigatorUniversity of Alabama at Birmingham
1 Previous Clinical Trials
39 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger